#Cipla Update
The #US #FDA ended its inspection at the company's arm's manufacturing facility in Goa and issued an observation in form 483.
#Stockmarketupdates #Nse #Nifty50
#Cipla #US #FDA #Stockmarketupdates #Nse #Nifty50